and proper functioning of mature cardiomyocytes, derived from the patient's somatic cells. The most important functional property of cardiomyocytes is the ability to contract. Currently available methods routinely used to test and quantify cardiomyocyte function involve techniques that are labor-intensive, invasive, require sophisticated instruments or can adversely affect cell vitality. We recently the ability of our analysis to characterize the chronotropic responses of human iPSC-derived cardiomyocytes to a panel of ion channel pharmacological compounds for cardiotoxic effects.
Introduction
Cardiovascular toxicity, a serious complication encountered during drug therapy, can lead to cardiomyopathy and heart failure. Many previously approved and marketed cardiac drugs have been withdrawn from the market due to severe side effects that became apparent only after the drugs were used in the clinics [1] . Developing a new drug is a very expensive and lengthy process-the current estimated cost to accomplish the Food & Drug Administration approval is about 1.5 billion USD [2] . Thus, substantial resources are wasted due to the limited predictive power of preclinical cardiotoxicity screening techniques. Therefore, it has been a persistent challenge for the pharmaceutical industry to either develop safe drugs that have no cardiac toxicity, or to optimize treatment combinations utilizing multiple agents that minimize druginduced damage to the heart. The most common harmful side effects which involve cardiac arrhythmias [3] , thus, there is a sustained need for preclinical (in vitro) drug screening assays that are especially sensitive to identify chronotropic effects and drug toxicity at the early stage of the drug development process.
Currently, the routinely used cardiotoxicity screening techniques involve sophisticated instruments and require some manipulation of the cells: clamping with electrodes, using dyes for intracellular imaging or mechanical indentation [4] . These methods are labor-intensive, invasive and can affect the cells' viability. Our recently developed method to quantify cardiomyocyte (CMC) contraction from video microscopic recording is manipulation free and technically simple. Thus, it is a promising approach to monitor CMC quality and maturity without compromising cell quality [5] . Primary human CMCs are difficult to obtain and cannot be kept for prolonged time periods in culture, hence they are not optimal for preclinical cardiotoxicity screening. Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes (iCMCs), in contrast, could provide an unlimited cell source for regenerative medicine and cardiotoxicity screens [6] [7] [8] . Earlier reports demonstrated that several drugs affect CMC beating frequency irrespective whether they were derived from embryonic or induced pluripotent stem cells, and are also compatible with clinical observations [9] [10] [11] . Most studies on iCMC responses, however, were utilizing electrophysiological readouts and the actual contractile kinetics of CMCs was ignored. We propose that our previously contractility kinetics can be a beneficial tool for preclinical drug screening. The method extracts a functional phenotype of the CMC culture and does not require manipulation of the cells. To determine the utility of our approach, we have evaluated how iCMC cultures respond to various pharmacological modulators of calcium (isoproterenol), potassium (NS1643, E4031) and sodium (veratridine, mexiletine) transport. We demonstrate that our assay successfully reproduced previously reported chronotropic effects. We trust that the hereby demonstrated reliability will motivate the application of the method to the early detection and prevention of cardiotoxic risk.
Materials and methods

Data availability
The source code of our analysis software is posted at https:// github.com/aczirok/piv-div, imaging data is shared at https://osf.io/qvdhn.
Antibodies and reagents
We used primary antibodies for cardiotroponin T (CTT), alpha channel antibody and anti-CACNA1S antibody 1A (Abcam) to perform in vitro analysis. As secondary antibodies, we used HRP-conjugated donkey anti-mouse, anti-rabbit, anti-goat -jugated donkey anti-mouse, anti-goat, and anti-rabbit (Jackson ImmunoResearch Laboratories, Inc) antibodies. We also medium (Stemgent, Cambridge, MA, USA) and FACS buffer Chronotropic compounds Several compounds were used to elicit changes in the spontaneous beating activity of iCMC cultures. The concentration for each drug was selected based on the review of cardio-active effects in previous studies [12] [13] [14] . Differentiation of iPSCs into CMCs -blasts as described in our earlier publication [5] were cultured in Nutristem medium on a matrigel coated -ing density of 10 6 cells/well. When the culture reached 80%--and recorded the beating of CMCs in the cultures from day six onwards.
Flow cytometer analysis Flow cytometry analysis was performed to characterize the CMC phenotypes as described earlier by us [15] from a six-well plate were harvested and labeled with primary -ondary antibodies. The relevant isotypes served as negative controls. Cells were washed three times with FACS buffer, -using FlowJo software (Tree Star, Ashland, OR, USA).
Protein expression was evaluated by immunofluorescence staining as previously described by us ---tion: ×60).
Western blot analysis
Western blot analyses of Oct4, Sox2 and Nanog proteins were performed in iPSC cells as described before using antibodies purchased from Cell Signaling Technology, USA.
Calcium imaging
Intracellular free Ca 2+ was measured in cells plated in dishes
Waltham, PA, USA) and pre-incubated in medium containing remove unincorporated calcium green, and imaged with a ×40 objective of a Nikon TE2000U confocal microscope, equiped
Images were obtained at 1 s intervals with a 488 nm Spectracence was recorded with a 515/30 nm band pass filter and transmitted light was collected separately to obtain a bright Particle image velocimetry (PIV) method We characterized cell contractility kinetics using our optical [5, 18] . High frame rate (10 frame/s) image sequences were recorded using a ×20 objective and a cooled microscope (Olympus TH4-100), equipped with a temperao C using the heated stage during 2-3 min long imaging sessions. CMC cultures were kept in cell culture incubators between imaging sessions.
A movement pattern (velocity field) captured on a pair of images was extracted by a two-stage predictor-corrector method described by us earlier [18] [19] [20] on frame-to-frame displacements, we identify reference frames in which CMCs are in the relaxed phase. We then characterized each frame of the recording using displacement vectors that are calculated relative to the appropriate reference frame.
torial average of displacement vectors within a 100-pixel wide area around the center of the cluster. The average difference between the maxima and minima of the beat pattern yield the amplitude of the beating center. Characteristic raise times were obtained as the time required the average beat waveform raises from 20% to 80% of the peak amplitude. Similarly, decay times were obtained as the time required for the average wave form to drop from 80% to 20% of the peak amplitude. In this study, we further analyzed beat patterns by Fourier spectrum analyses and presented power density spectra as heat maps. The source code of the analysis software is available at http://github.com/aczirok/piv-div Fourier and power density spectra Fourier spectra, F(f), were calculated from beat patterns using the discrete Fourier transform algorithm. Power density spectra, P(f), were obtained as P(f)=|F(f)| 2 , and were used to indicate periodicity within the signal in the form of peaks at the corresponding frequencies. If the analyzed signal is not a pure sine wave, the appearance of harmonics are expected at integer multiples of the fundamental frequency f (2f, 3f, etc). The magnitude of a peak in the power spectrum indicates the amplitude of the signal oscillating with the corresponding frequency. Unfortunately, the beat pattern is not stationary over yields an increasing baseline. This artifact reduces the reliability of the Fourier components corresponding to very low frequencies. Hence, frequencies around zero, representing signals with periods longer than quarter of the duration of the recording, were excluded from our analysis.
Power density spectra of multiple beat patterns, typically recorded at progressively later time intervals, are presented as heatmaps. In these images, the horizontal and vertical axes indicate the individual samples and the frequencies, respectively. Amplitudes are color coded according to a linear scale. Power density heat map plots thus allow an unbiased, quantitative characterization of changes in beat frequencies.
Modeling
The membrane potential and ionic currents were modeled using the OpenCOR (www.opencor.es) platform. The CellML [21] was obtained from models.cellml.org. Activation or blockage of ion channels was represented by increasing or decreasing the affected ion current by 50% compared to the published (baseline) scenario.
Statistical analysis
All experiments were repeated at least 3 times. Results are presented as mean±SEM. Comparisons were performed by 2 test for percentages. All tests were 2-sided, and probability values less
Results
Characterization of day 14 human iPSC-derived cardiomyocytes Human iPSC-derived cardiomyocytes (iCMCs) were generated using culture conditions conducive for cardiac differentiation as described by us earlier [5] . From in vitro day six onwards, iCMCs exhibited spontaneous beating which can be observed by phase contrast microscopy. Day 14 iCMCs were harvested to evaluate the presence of CMC-specific proteins cells are positive for cardiac specific markers, either cardiac troponin T (CTT) or Nkx2.5 ( Figure 1A ). To characterize the maturation process of iCMCs, we investigated the presence in vitro age and 30 iCMC cultures revealed a substantial and progressive increase in the amount of cardiac proteins of hyperpolarization activated cyclic nucleotide gated potassium channel 4
To characterize which CMC types develop within the cardiac-specific differentiation culture, we have performed immunofluorescence analysis identifying myosin light chain population of day 14 iCMCs were heterogeneous, consisting of both MLC2a positive and MLC2v positive cells ( Figure 1C ). cytometry analysis indicating that 86.3% of cells were positive -col was more supportive for the differentiation towards venIn addition to the presence of appropriate molecular markers, transmission electron microscopic image analysis of day 14 - tern of sarcomeres ( Figure 1D ). Functional CMCs also require the expression of appropriate Ca 2+ + and Na + channels [22] , their presence was verified by immunofluorescence analysis ( Figure  S2 ). Overall, these data suggest that by day 14 iCMC cultures contain functional cardiomyocytes, and cultures of this age were subjected to our optical beat pattern analysis.
Contactless cardiac contractility analysis
To characterize chronotropic alterations in CMC beat frequency, we recorded the spontaneous beating activity of the same iCMC cluster at various time points using video microsmade one hour after refreshing the culture medium, served as a baseline. Then, we administered the drug into the culture medium and recorded beat activity periodically. One of these recordings took place 2 h after the addition of the drug, and we used this recording to establish the steady-state effect of the compound (see below). After a treatment window of 2-4 h, the drug containing medium was removed, the cells fresh medium. Finally, 18 h after the wash, the recovered iCMC culture was recorded again to evaluate the reversibility of the pharmacological effects.
technique [5] yielding beat patterns-tissue displacement as a function of time, measured relative to a resting reference state.
to a contractile event. The duration of the raising and falling slopes of the peaks thus estimate the length of the electrophysiological plateau and repolarization phases, respectively ( Figure   to Fourier analysis, and the dominant beat frequencies were visualized on power density spectrograms. Periodicity within the beat pattern is indicated in the power spectra by a peak at the corresponding frequency. The magnitude of a peak is related to the amplitude of the signal oscillating with the corresponding frequency ( Figure S2C ). Thus, CMC beat patterns are characterized by two numbers, the spontaneous beat frequency of multiple beat patterns, typically recorded at progressive time intervals, are presented as heat maps ( Figure S2D) .
For each drug, we compare the baseline with the 2 h post- for immunostaining images and 500 nm for TEM.
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Acta Pharmacologica Sinica treatment and the 18 h post-wash data. To reduce the effect -0 0 ), 0 ) 0 ) measures, respectively. To establish the quality and reproducibility of our drug screening procedure, we performed our experimental protocol with adding only a treatment vehicle, DMSO. Comparison of the baseline, 2 h post-treatment and 18 h postdifferences. Normalized frequency and amplitude values are compared to 1, which is represented by the horizontal dotted -putational analysis of iCMC cultures indicates that the spontaneous beat frequency or amplitude was stable during the time period selected for chronotropic analysis. The average raise and decay times of the beat patterns were obtained from (n=8) averaged waveforms yielding 0.12±0.02 and 0.20±0.05 s, respectively ( Figure S2F ). that cultured iCMCs expressed Ca 2+ channels encoded by the CACNA1S gene that are required for the polarization-repolarization cycles in cardiac muscle ( Figure S3A ). Isoproterenol -lular Ca 2+ dynamics, induced a substantial and sustained increase in beating frequency without triggering arrhythmias Power spectra of consecutive recordings are shown as a heat The reversibility of the isoproterenol effect is indicated by (Figure 2A, E) . In summary, 800 nmol/L isoproterenol in P P of the average beat pattern, respectively (P<0.01, Figure 2F ). Therefore, iCMCs exhibit a physiologic chronotropic response Voltage-gated potassium channel regulators regulator to generate action potential currents for spontaneous beat pattern in CMCs [23] NS1643 [24] [25] to study their chronotropic and ionotropic effects in human iCMC cultures. Figure 3D-F) .
Beta-adrenergic calcium channel regulator
larization phase of the action potential in human CMCs [26] . Figure 4 , Supplemental Movie 3). Figure 4F ): the contraction and resting phases appear P increased, but tended to remain below the baseline level with P=0.05, Figure 4D , E). For E4031 we also compared our optical analysis with a more traditional calcium transient imaging method, and obtained a similar response and E4031 exerts potent positive and negative chronotropic contraction cycle.
P<0.01,
P<0.001,
Voltage-gated sodium channel regulators + channels are the third essential components of the action potential oscillator. We therefore, examined the roles of the voltage gated Na + channel activator veratridine and blocker mexiletine [28] on the spontaneous beating proper--
Our optical beat pattern analysis shows that 50 nmol/L of the Na + channel activator veratridine significantly increases P=0.096, Figure 5 , Supplemental mainly due to a longer relaxation phase and a 50% increase in the raise time to 0.20±0.02 s (P<0.01, Figure 6F ). In cultures of iCMCs, thus, the Na channel activator and blocker had a positive and negative chronotropic effect, respectively. 
Computational model
regulators, we implemented the perturbations in a computational model of cardiomyocyte electrophysiology. We used [21] as it represents the ion channels relevant for our experiments but lacks additional modeling complexity. In the computational model activation or blockage of ion channels was represented by increasing or decreasing the affected ion current by 50% compared to the baseline scenario.
rents determine the length of the plateau and repolarization the plateau and repolarization phases and decrease the freAs voltage-gated fast Na + channels are responsible for the depolarization phase through a self-amplifying process, inactivation of a population of Na channels lengthened the resting to the underlying positive feedback, once depolarization is initiated, the membrane potential continues to rise rapidly. Na channels are mostly closed in the repolarization and plateau phases, which are thus not affected by inactivation of Na channels. Persistent activation of Na channels, in contrast, have two opposite effects: by increasing the membrane potential, it promotes an earlier onset of the depolarization phase. The The net impact on the beat frequency of these opposing effects was sensitive to model parameters. The default parameters
In addition to ion channel modulators, we demonstrate the the well-known cardiotoxic side effects of a chemotherapeutic agent, doxorubicin [29] . For this, the iCMCs were cultured in the presence and absence of 10 mol/L doxorubicin for 5 h. Doxorubicin exposure resulted in a transient increase, then an P<0.01, Figdue to the lengthening of the resting phase: the contraction (P sensitive enough to detect clinically relevant cardiotoxicity.
Discussion
Currently, the incidence of cardiac and non-cardiac drug reactions is excessive in patients due to the limited capacity of preclinical screening to detect cardiotoxicity. Development of new medications that are free from adverse cardiac side effects is especially hampered by the lack of an appropriate in vitro assay for human cardiac tissue. Human iCMCs emerge as an inexpensive and easily available source of human heart cells for pharmacological screening and drug toxicity assays. In particular, a recent study has shown that iCMCs derived from a long QT syndrome (LQTS) patient can be used to evaluate the potency of existing and novel pharmacological agents that are regulating various ion channels [9] . Similarly, iCMCs derived from dilated cardiomyopathy (DCM) patients resemble to some extent to the morphological and functional phenotypes of DCM and are serving as a useful tool for exploring disease mechanism and drug screening [11] . This method also circumvents many hurdles associated with transgenic animal models that have been previously used for studying several cardiovascular disorders. In particular, iCMCs with a certain genetic makeup can be obtained much faster than the corresponding transgenic mice. Furthermore, human and mouse cells have physiological dif- ferences, like their intrinsic heartbeat frequency, that can also modulate the chronotropic effect of certain pharmacological compounds. Usage of iCMCs also reduces reliance on animal models and may indicate problems before the expensive clinical trial phases of the approval process. Current in vitro safety pharmacology guidelines suggest that all new drugs need to undergo evaluation for major functional changes in cardiac ion channels to rule out potential cardiotoxicity. While iCMCs are often immature when compared with primary adult cardiomyocytes, the iCMCs generated in this study were mature and phenotypically and morphologically closely related to adult and electron microscopic image analyses. Although there are a few drug screening models available utilizing ESC or iPSC-derived cardiomyocytes, most published approach uses either Ca 2+ transient imaging or patch clamping, which restricts their application in high-throughput settings [4] . In this study, we systematically analyzed small molecule mediated spatio-temporal functional effects and cardiotoxicity in iCMCs using our previously described contact- [5] . Changes in the frequency and amplitude of the spontaneous CMC beating activity were characterized by an unbiased Fourier spectrogram analysis that represents frequency shifts in a heat map format. Fourier spectrogram heat maps also allow to determine pharmacokinetic parameters such as the time required to reach peak effect, or the stability of the compound in this model system. Our approach is simple, fast and requires only unsophisticated phase contrast video microscopic imaging capability to assess how drugs affect the kinetics of spontaneous beating activity of cardiomyocytes. Here we analyzed various modulators of Ca 2+ + and Na + ion channel dynamics, key regulators of action potential generation.
Studies have reported that L-type calcium channels play critical roles in cardiac contractile function [30] . Isoproterenol is cAMP pathway and enhances contractile function. However, increased signaling also leads to cardiac hypertrophy and in some cases to heart failure [31] . Clinically, isoproterenol is used to treat bradycardia, congestive heart failure and heart block [32] . To evaluate the effect of this drug in our in vitro system, we have analyzed the spontaneous beating activity data suggest that in agreement with the available clinical CMCs.
+ channels (I ), is an antiarrhythmic drug increasing heartbeat frequency and contractile force [33, 34] . Most commonly, QT interval prolongation is due to reductions in either the rapidly activating (I ) or by slowly activating (I ) mediated delayed repolarizing car-+ current. Clinically, NS1643 has been shown to affect amplitude. Overall, our data demonstrate that day 14 iCMCs were in agreement with the clinical benefits. These effects were reversed by the potassium channel blocker, E4031, which is used to prolong repolarization and increase maximum diastolic potential. E4031 is an experimental class III antiarrhyth-
. In a recent study, E4031 was used to suppress the spontaneous development of different beating frequencies among cardiomyocytes [36] . In our in vitro study, we observed that E4031 mediated reduction of the I current prolonged the contraction of CMCs, likely by increasing the duration of the repolarization phase of the cardiac action potential. This effect also leads to E4031 exerts a negative chronotropic and ionotropic effects on channel modulators as novel antiarrhythmic agents.
of Liliaceae family. It functions by preferentially binding to activated Na + channels causing their persistent activation . Recent studies have shown that veratridine also affects the function of Na + channels in CMCs [38, 39] . Our in vitro data also indicates a negative chronotropic effect of veratridine on iCMCs in agreement with an earlier report [39] . In contrast, mexiletine is a non-selective voltage gated Na + changroup of medicine. Clinically it is used to reduce ventricular tachycardia and to stabilize the heart rhythm in cases like ventricular premature beat. It has also been shown that mexiletine reduces Na + current in atrial and ventricular myocytes [40] . In [40] . -diac modulators and exert relatively strong effects on cardiac functions. To mimic cardiotoxicity screening of an anti-cancer drug, we also analyzed iCMCs before and during doxorubicin treatment. Our data clearly shows that there is an irreversible reduction in both beat frequency and amplitude which is in agreement with an earlier report [29] . In conclusion, we demonstrated the feasibility of measuring clinically relevant CMC functions through a non-contact optical analysis yielding both spontaneous beat frequency and amplitude. Comparing with the available methods, our new method has several advantages such as being manipulationfree, less invasive, user friendly, inexpensive and has a supe--ing anti-cancer drugs. Thus, we expect our CMC monitoring method to become a useful and novel tool to assess drug effects and cardiotoxicity in preclinical drug screening.
